Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. L. B. Cabral, L. M. Gericke, R. M. Barbirotto, M. A. Martins (Sao Paulo, Brazil). Are exhaled nitric oxide and airway hyperresponsiveness good predictive markers of inhaled corticosteroids dose reduction failures in children?. Eur Respir J 2003; 22: Suppl. 45, 3584

Member's Comments

No comment yet.

Related content which might interest you: The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007 Measurement of exhaled nitric oxide can not reliably predict exacerbations in school-aged asthmatic children using inhaled corticosteroids Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels Source: International Congress 2017 – Monitoring asthma control Year: 2017 Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship Source: Eur Respir J 2002; 20: 601-608 Year: 2002 Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 429s Year: 2004 Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study Source: Eur Respir J 2014; 44: 1705-1707 Year: 2014 Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma Source: Eur Respir J 2001; 18: 635-639 Year: 2001 Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 270s Year: 2004 Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004